E09.64 Drug or chemical induced diabetes mellitus with hypoglycemia

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Hypoglycemia (ICD-10 Code: E09.64)

Summary

Drug or chemical induced diabetes mellitus with hypoglycemia is a condition where exposure to specific medications or chemicals disrupts glucose metabolism, leading to abnormally low blood sugar levels (hypoglycemia). This form of diabetes is directly attributable to external factors that impair insulin regulation, resulting in hyperglycemia followed by episodes of hypoglycemia. The condition requires careful management to prevent both hyperglycemic and hypoglycemic complications.

Causes

The condition is caused by exposure to drugs or chemicals that alter glucose regulation, leading to uncontrolled fluctuations in blood sugar. Common culprits include medications (e.g., insulin, sulfonylureas, or certain antibiotics) and toxins that either increase insulin secretion or reduce glucose production. These substances trigger hypoglycemia, which may occur as a direct effect or as a rebound after hyperglycemia.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., insulin, oral hypoglycemics).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Dosage and duration of exposure to the causative agent.
• Inadequate monitoring of blood glucose levels.

Symptoms

• Shakiness, dizziness, or lightheadedness.
• Confusion, irritability, or difficulty concentrating.
• Sweating, palpitations, or tremors.
• Hunger or nausea.
• Fatigue or weakness.
• In severe cases, loss of consciousness or seizures.

Diagnosis

Diagnosis involves a thorough patient history to identify potential drug or chemical exposure, followed by blood glucose testing to confirm hypoglycemia. Additional tests may include measuring insulin levels, C-peptide, or screening for toxins. Documentation of the temporal relationship between exposure and symptoms is critical for establishing causality.

Treatment Options

Treatment focuses on discontinuing the causative agent and managing blood glucose levels. Acute hypoglycemia is treated with fast-acting carbohydrates (e.g., glucose tablets or juice), while long-term management may involve adjusting medications, monitoring blood sugar, or using alternative therapies. Underlying causes, such as toxin exposure, must be addressed to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of hypoglycemia and the timeliness of treatment. Most cases resolve with discontinuation of the offending agent and proper glucose management. Follow-up includes regular blood glucose monitoring, medication adjustments, and education on recognizing and preventing hypoglycemic episodes.

Complications

• Severe hypoglycemia leading to loss of consciousness or seizures.
• Long-term neurological damage from recurrent episodes.
• Cardiovascular events due to blood sugar fluctuations.
• Impaired quality of life from frequent monitoring and management.

Lifestyle & Prevention

• Avoid or limit exposure to known causative drugs or chemicals.
• Maintain a balanced diet and regular meal schedule to stabilize blood sugar.
• Carry fast-acting carbohydrates for emergencies.
• Educate family and caregivers on recognizing and treating hypoglycemia.
• Regularly review medications with a healthcare provider to identify potential risks.

When to Seek Professional Help

Seek immediate medical attention if experiencing symptoms of severe hypoglycemia (e.g., confusion, seizures, or loss of consciousness). Contact a healthcare provider for persistent or recurrent episodes, or if new medications or chemicals are introduced that may affect blood sugar.

Tips for Medical Coders

Document the specific drug or chemical exposure and its relationship to hypoglycemia. Include details on the timing of symptoms relative to exposure, diagnostic test results, and treatment interventions. Ensure the code E09.64 is used only when hypoglycemia is the primary complication of drug or chemical induced diabetes mellitus.